MiR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RHoGDi1 and ALCAM

Cancer Research

Volumn 74, Issue 11, 2014, Pages 3031-3042

  Song, Qiancheng ^a   Xu, Yuanfei ^a   Yang, Cuilan ^a   Chen, Zhenguo ^a   Jia, Chunhong ^a   Chen, Juan ^a   Zhang, Yue ^a   Lai, Pinglin ^a   Fan, Xiaorong ^a   Zhou, Xuan ^a   Lin, Jun ^a   Li, Ming ^a   Ma, Wenli ^a   Luo, Shenqiu ^a   Bai, Xiaochun ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA CATENIN; MICRORNA; MICRORNA 483 3P; MICRORNA 483 5P; NERVE CELL ADHESION MOLECULE; PROTEIN CDC42; RAC PROTEIN; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; WNT PROTEIN; 3' UNTRANSLATED REGION; ALCAM PROTEIN, HUMAN; FETOPROTEIN; LEUKOCYTE ANTIGEN; MIRN483 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG METASTASIS; METASTASIS POTENTIAL; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; TUMOR INVASION; TUMOR PROMOTION; UPREGULATION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DISEASE COURSE; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; ANIMALS; ANTIGENS, CD; BETA CATENIN; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FETAL PROTEINS; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR ALPHA; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84902157182     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2193     Document Type: Article

References (44)

1. Gupta GP, Massague J. Cancer metastasis: building a framework. Cell 2006;127:679-95.
2. Thiery JP, Acloque H, Huang RYJ, Angela Nieto M. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871- 90.
3. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
4. Anastas JN, Moon RT.WNTsignalling pathways as therapeutic targets in cancer. Nat Rev Cancer 2013;13:11-26.
5. Yook JI, Li XY, Ota I, Hu C, Kim HS, Kim NH, et al. A Wnt-Axin2-GSK3 beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol 2006;8:1398.
6. Nakashima T, Liu D, Nakano J, Ishikawa S, Yokomise H, Ueno M, et al. Wntl overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients. Oncol Rep 2008; 19:203-9.
7. Nguyen DX, Chiang AC, Zhang XHF, Kim JY, Kris MG, Ladanyi M, et al. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009;138:51-62.
8. Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, et al. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer. Hum Pathol 2008;39:126-36.
9. Choi YS, Shim YM, Kim S-H, Son DS, Lee H-S, Kim GY, et al. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2003;24: 441-9.
10. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin, and cancer metastasis. Nat Cell Biol 2010;12:247.
11. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, et al. A pleiotropically acting microrna, mir-31, inhibits breast cancer metastasis. Cell 2009;137:1032-46.
12. Akao Y, Nakagawa Y, Naoe T. MicroRNA-143 and-145 in colon cancer. DNA Cell Biol 2007;26:311-20.
13. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007;449: 682-8.
14. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008;451:147-52.
15. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601.
16. Stinson S, Lackner MR, Adai AT, Yu N, KimH-J, O'Brien C, et al. TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal 2011;4:ra41.
17. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Ann Rev Med 2009;60:167-79.
18. Wang L, Shi M, Hou S, Ding B, Liu L, Ji X, et al. MiR-483-5p suppresses the proliferation of GLIOMA cells via directly targeting ERK1. FEBS Lett 2012;586:1312-7.
19. Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 2011;117:1630-9.
20. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, et al. miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res 2009;15:7684-92.
21. Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F, et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res 2010;70:3140-9.
22. Moussay E, Wang K, Cho JH, van Moer K, Pierson S, Paggetti J, et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2011;108:6573-8.
23. Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg 2008;12:2171-6.
24. Camp RL, RimmEB, Rimm DL. Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma. Cancer 1999;86:2259-65.
25. Cheng YW, Wu NF, Wang J, Yeh KT, Goan YG, Chiou HL, et al. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation. Cancer Res 2007;67:10686-93.
26. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafa R, et al. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 2012;142:886-969.
27. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37: 495-500.
28. Grimson A, Farh KKH, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007;27:91-105.
29. Smith TK, Hager HA, Francis R, Kilkenny DM, Lo CW, Bader DM. Bves directly interacts with GEFT, and controls cell shape and movement through regulation of Rac1/Cdc42 activity. Proc Natl Acad Sci U S A 2008;105:8298-303.
30. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor Snail controls epithelial- mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
31. Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, Mah V, et al. Snail promotes CXCR2 ligand-dependent tumor progression in non- small cell lung carcinoma. Clin Cancer Res 2009;15:6820-9.
32. Veronese A, Visone R, Consiglio J, Acunzo M, Lupini L, Kim T, et al. Mutated beta-catenin evades a microRNA-dependent regulatory loop. Proc Natl Acad Sci U S A 2011;108:4840-5.
33. Kobayashi T, Shimura T, Yajima T, Kubo N, Araki K, Tsutsumi S, et al. Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of beta-catenin. Int J Cancer 2011;129:2775-86.
34. Fu H, Tie Y, Xu C, Zhang Z, Zhu J, Shi Y, et al. Identification of human fetal liver miRNAs by a novel method. FEBS Lette 2005;579:3849-54.
35. Sahai E, Marshall CJ. RHO: GTPases and cancer. Nat Rev Cancer 2002;2:133-42.
36. Garcia-Mata R, Boulter E, Burridge K. The 'invisible hand': regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol 2011;12:493-504.
37. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K, et al. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 2003;9:6432-40.
38. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 2010;12:390.
39. Ofori-Acquah SF, King JA. Activated leukocyte cell adhesion molecule: A new paradox in cancer. Transl Res 2008;151:122-8.
40. Weichert W, Knoesel T, Bellach J, Dietel M, Kristiansen G. ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 2004;57:1160-4.
41. Jin Z, Selaru FM, Cheng Y, Kan T, Agarwal R, Mori Y, et al. MicroRNA- 192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro. Oncogene 2011;30:1577-85.
42. van Kempen LC, van den Oord JJ, van Muijen GN, Weidle UH, Bloemers HP, Swart GW. Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am j Pathol 2000;156:769-74.
43. Verma A, Shukla NK, Deo SVS, Gupta SD, Ralhan R.MEMD/ALCAM: A potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology 2005;68:462-70.
44. Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, et al. ALCAM/CD166 is upregulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 2003;54:34-43.